Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AstraZeneca’s Head Of R&D Asia Patrick Keohane On Balancing East And West: An Interview With PharmAsia News (Part 2 of 2)

This article was originally published in PharmAsia News

Executive Summary

AstraZeneca's Head of R&D in Asia Patrick Keohane sat down recently with PharmAsia News' Australia bureau to talk about AstraZeneca's footprint in Asia and how the company's thinking is changing as a result of looking toward Asia.

You may also be interested in...



Despite Global Financial Crisis, China Pharma Market Expected To Grow At 20% Over Next Several Years

SHANGHAI - Despite the financial downturn, IMS China recently reported a 26 percent increase in growth for China's pharmaceutical market in 2008, bringing the total size of the market to approximately $25 billion. The growth rate is expected to hold steady at around 20 percent for the next several years, according to IMS Health analysts

Despite Global Financial Crisis, China Pharma Market Expected To Grow At 20% Over Next Several Years

SHANGHAI - Despite the financial downturn, IMS China recently reported a 26 percent increase in growth for China's pharmaceutical market in 2008, bringing the total size of the market to approximately $25 billion. The growth rate is expected to hold steady at around 20 percent for the next several years, according to IMS Health analysts

AstraZeneca Extends RSV Deal With Aussie Biotech Biota

PERTH, Australia - Melbourne-based Biota's 2005 antiviral collaboration and license agreement with MedImmune has been picked up by AstraZeneca and expanded to include a number of Asian territories, Biota announced Aug. 25

Related Content

UsernamePublicRestriction

Register

LL038093

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel